Parkinson's Disease and Cosmetic Surgery: Why Levodopa Timing Matters More Than the Anesthetic, Which Anti-Nausea Drugs and Painkillers to Avoid, What a Deep Brain Stimulator Means for Facelifts and Energy Devices, and How to Plan a Recovery Around Swallowing, Blood Pressure, and Falls

The patient is 63, was diagnosed with Parkinson's disease four years ago, and takes carbidopa-levodopa four times a day along with rasagiline. The tremor in their left hand is mild, their walking is steady when the medication is working, and they want a lower facelift and an upper eyelid lift. The consultation went smoothly until the intake form reached "neurological conditions." Then the conversation shifted to whether they were "a candidate at all," with a request for neurology clearance and a vague comment that the anesthesia "could make things worse." Nobody asked what time they take their pills.

That last question is the one that matters most. The Parkinson's Foundation estimates that nearly one million people in the United States live with Parkinson's disease, with about 90,000 new diagnoses a year, and the large majority are in the age range where facelifts, eyelid surgery, and skin cancer reconstruction are common. Parkinson's disease is not, by itself, a reason to refuse elective surgery. But it changes the operating day and the recovery week in specific, predictable ways, and most of the serious problems that patients with Parkinson's run into in hospitals come from a short list of avoidable mistakes rather than from the operation.

This piece covers why medication timing outranks the anesthetic, which commonly used surgical drugs are a poor fit, how a deep brain stimulator changes the plan for facial and chest surgery and for energy devices, how to manage swallowing, blood pressure, bowels, and falls during recovery, and what Parkinson's means for injectables and skin. It builds on the earlier pieces on anesthesia and the operative plan and pre-operative testing, and it belongs to the series on chronic conditions that includes epilepsy and multiple sclerosis.

Why the levodopa clock matters more than the anesthetic

The short answer: levodopa has a short half-life of roughly 90 minutes, so a delayed or skipped dose on the day of surgery can quickly produce rigidity, tremor, swallowing difficulty, and immobility, and an abrupt stop can trigger a rare but dangerous reaction, which is why Parkinson's medications are treated as time-critical and should be taken on schedule throughout the surgical day.

Parkinson's UK runs a long-standing campaign called "Get It On Time," built on surveys and audits showing that many hospital patients with Parkinson's miss or receive late doses, and that late doses are associated with longer stays and more complications. The American experience is similar, and the Parkinson's Foundation promotes the same principle through its hospital safety materials. The reason is pharmacological. Levodopa, the core treatment for most patients, is cleared from the blood within a few hours. Patients who have had the disease for several years often develop "wearing off," in which symptoms return before the next dose is due. For these patients, a two-hour delay is not an inconvenience. It can mean the difference between walking to the bathroom and being unable to roll over in bed.

The surgical day is full of ways to miss a dose:

• Fasting instructions read as "take nothing." Patients told not to eat after midnight skip their morning pills. Current American Society of Anesthesiologists guidance allows clear liquids up to two hours before anesthesia in most healthy adults, and Parkinson's medications should be taken on schedule with a sip of water unless the anesthesiologist specifically says otherwise.
• Afternoon start times. A case that begins at 2 p.m. after a delay can straddle two doses. Patients with Parkinson's should ask to be the first case of the morning.
• Recovery room routines. The post-anesthesia unit may not stock the patient's exact formulation or may wait for a pharmacy order. Patients should bring their own labeled medication, in the original containers, and the timing should be written into the recovery orders.
• Nausea and vomiting. A dose that comes back up has not been absorbed. Nausea prevention matters more here, for reasons the next section explains, and the general strategies are covered in the piece on nausea after cosmetic surgery.

There is no standard intravenous levodopa in routine American surgical use, so the plan for a patient who cannot swallow needs to exist before the day, not during it. The options include a rotigotine skin patch (a dopamine agonist), levodopa given through a temporary feeding tube in longer hospital stays, injectable apomorphine for patients who already use it, and, for a small number of patients with advanced disease, a subcutaneous infusion of foslevodopa and foscarbidopa approved by the FDA in 2024. Most cosmetic procedures are short enough that none of this is needed, provided the doses before and after the operation happen on time.

The rare but serious reason to avoid gaps is parkinsonism-hyperpyrexia syndrome, sometimes called dopamine withdrawal syndrome. An abrupt stop of dopaminergic medication can produce high fever, severe rigidity, confusion, and muscle breakdown, closely resembling neuroleptic malignant syndrome. It is uncommon, but it has been reported after surgery when medications were held for fasting. A fever with stiffness in a patient whose doses were interrupted is not a routine post-operative fever, a distinction worth knowing from the piece on fever after plastic surgery.

Protein timing deserves a footnote. Dietary protein competes with levodopa for absorption, and some patients time their doses around meals. The light, often protein-heavy recovery meals that nutrition advice recommends, discussed in the piece on pre-op nutrition optimization, may need to be spaced around doses rather than taken with them.

The drug list: anti-nausea medicines, painkillers, and MAO-B inhibitors

The short answer: several anti-nausea drugs commonly used in surgery work by blocking dopamine and can sharply worsen Parkinson's symptoms, and patients taking MAO-B inhibitors such as rasagiline, selegiline, or safinamide should avoid meperidine, tramadol, methadone, and dextromethorphan, while ondansetron must not be combined with apomorphine.

This is the section most worth printing and handing to the anesthesiologist, because the risky drugs are routine choices in many practices.

Anti-nausea drugs that block dopamine. Metoclopramide (Reglan), prochlorperazine (Compazine), promethazine, droperidol, and haloperidol all block dopamine receptors, which is the opposite of what a patient with Parkinson's needs. The Parkinson's Foundation's hospital materials list them among the medications to avoid. A single dose can cause a marked worsening of rigidity and slowness that may last for days. Some of these drugs are also prescribed casually for home use after surgery, so the discharge prescription matters as much as the anesthetic.

Anti-nausea drugs that generally fit. Ondansetron and related 5-HT3 blockers, dexamethasone, and certain antihistamines are generally acceptable, with one important exception: ondansetron and other 5-HT3 blockers are contraindicated with apomorphine because the combination can cause profound low blood pressure and loss of consciousness. Patients who carry an apomorphine pen for "off" episodes must say so. Opioid-sparing pain control reduces nausea in the first place, which is one reason the approach in the piece on opioid-sparing recovery suits these patients particularly well.

MAO-B inhibitors and painkillers. Rasagiline, selegiline, and safinamide block an enzyme that breaks down dopamine. Combined with meperidine, tramadol, methadone, or dextromethorphan (the cough suppressant in many over-the-counter cold products), they carry a warning for serotonin syndrome, a reaction marked by agitation, fever, sweating, and muscle twitching. Tramadol in particular is sometimes offered as a "milder" option after cosmetic surgery, which is exactly the wrong instinct here. Patients also taking an SSRI or SNRI antidepressant, common in Parkinson's because depression and anxiety are frequent, add another serotonergic layer, and the bleeding side of those drugs is covered in the piece on SSRIs and surgical bleeding. Product labeling for MAO-B inhibitors also advises caution with some decongestants and sympathomimetic drugs, which is a reason to tell the anesthesia team before any vasopressor or epinephrine-containing local anesthetic is chosen, even though standard doses are generally manageable.

Sedatives and confusion. Benzodiazepines and anticholinergic drugs (including some given for nausea, bladder spasm, or sleep) raise the risk of confusion and hallucinations, which are already more common in Parkinson's. Postoperative delirium is more frequent in patients with Parkinson's than in the general surgical population, and the general picture is covered in the piece on brain fog after anesthesia. Patients with Parkinson's-related psychosis who take quetiapine, clozapine, or pimavanserin should keep taking them, and older antipsychotics should be avoided entirely for the reason given above.

"

For a patient with Parkinson's, the riskiest moment of the surgical day is often not the anesthetic. It is the morning pill skipped for fasting, the dose that runs late in recovery, and the anti-nausea injection that blocks the very chemical the patient is missing.

"

The neurology letter, if one is requested, should answer these points directly rather than offer a single line of clearance: the exact regimen with doses and clock times, any "off" episodes and how long they last, rescue medications, swallowing status, history of orthostatic low blood pressure or falls, any history of hallucinations or confusion, and whether the patient has a deep brain stimulator. A list like that lets the anesthesiologist plan. "Cleared for surgery" does not.

Deep brain stimulators, energy devices, and where the wires run

The short answer: deep brain stimulation systems have leads in the brain, extension wires tunneled under the scalp behind the ear and down the side of the neck, and a pulse generator usually placed below the collarbone, so facelifts, neck lifts, and breast or chest procedures must be planned around the hardware, electrocautery settings must follow manufacturer guidance, and diathermy treatments are contraindicated.

Deep brain stimulation is an established treatment for Parkinson's disease, and the anatomy of the system matters more to plastic surgeons than to almost any other specialty. The extension wire typically runs from a connector on the skull behind the ear, down the side of the neck under the skin, to a generator in the upper chest. That path crosses the territory of a facelift incision behind the ear, the skin flap of a neck lift, and, depending on placement, the upper pole of a breast augmentation or the incision of a chest procedure.

Several practical consequences follow:

• Surgical planning around the wire. A facelift or neck lift in a patient with a stimulator requires knowing exactly where the extension wire and connector sit, ideally from the implanting team's records and imaging. Undermining the skin near the wire risks damaging it or exposing it, and a damaged lead means another operation by a neurosurgeon. The general mechanics of how far facelift dissection travels are described in the piece on the deep plane facelift, and the neck work is described in the piece on neck lift and platysmaplasty.
• Electrocautery. Manufacturer guidance generally favors bipolar over monopolar cautery near the system, places the return electrode so current does not pass through the generator or leads, and often calls for the stimulator to be switched off or set to a specific mode during surgery. The logic mirrors cardiac devices, covered in the piece on pacemakers and defibrillators before cosmetic surgery. The difference is that turning a stimulator off can bring back severe tremor and rigidity within minutes, which affects how a patient under local anesthesia or light sedation tolerates the procedure.
• Diathermy is off the table. Deep brain stimulator labeling has long carried a strong warning against shortwave, microwave, and therapeutic ultrasound diathermy anywhere on the body, because heating at the electrode tips has caused serious brain injury. Patients should never assume a spa or clinic "heat" treatment is safe without checking its mechanism.
• Radiofrequency and energy devices. Radiofrequency microneedling, monopolar radiofrequency tightening, and some body-contouring devices deliver current or heat into tissue. Whether a given device is acceptable depends on its mechanism, the treatment area, and the stimulator manufacturer's guidance, and devices that work near the neck, scalp, or chest deserve particular caution. The range of these treatments is reviewed in the piece on energy-based skin tightening.

Patients without a stimulator should still tell their surgeon if they are being evaluated for one. A facelift placed shortly before a neurosurgeon needs to tunnel a wire through the same tissue complicates both operations, and the sequencing is worth a conversation between the two surgeons.

Swallowing, blood pressure, bowels, and falls during recovery

The short answer: Parkinson's commonly brings swallowing difficulty, low blood pressure on standing, severe constipation, bladder problems, and fall risk, and each is magnified in the first week after surgery, so recovery planning should include aspiration precautions, slow position changes, an aggressive bowel plan, and a home set up for unsteady walking.

Many of the hardest parts of recovery for these patients have nothing to do with the incision.

Swallowing and aspiration. Difficulty swallowing is common as Parkinson's progresses, and it can be subtle. Sedation, a sore throat from a breathing tube, and opioids all make it worse, increasing the risk that food, liquid, or saliva goes into the airway. Patients with known swallowing problems should tell the anesthesia team, may benefit from a swallowing assessment before surgery, and should expect a more cautious approach to sedation and airway management. The routine throat irritation after intubation, covered in the piece on sore throat after a breathing tube, can be more consequential when the swallow is already weak.

Orthostatic low blood pressure. Parkinson's affects the autonomic nervous system, and many patients experience a drop in blood pressure on standing, which their medications can make worse. After surgery, fluid shifts, opioids, and blood loss add to it. The first time a patient stands after an operation should be slow, with help, and with a pause at the edge of the bed.

Constipation and bladder problems. Constipation is one of the most common non-motor features of Parkinson's, often preceding the diagnosis by years. Opioids and reduced activity after surgery can turn it into a serious problem quickly, so a bowel regimen should start on the day of surgery, not after several days without a movement. The standard plan in the piece on constipation after plastic surgery should be considered the minimum. Bladder urgency and incomplete emptying are also common, and the risk of retention after anesthesia, described in the piece on urinary retention after plastic surgery, is higher, particularly in men with enlarged prostates.

Falls. A patient with Parkinson's who is wearing a compression garment, carrying drains, groggy from medication, and dizzy on standing is at real risk of falling. Freezing of gait, a sudden inability to step forward, often happens in doorways and turns. The caregiver arrangements described in the piece on the recovery house and the first 72 hours should include a clear path to the bathroom, a night light, a chair in the shower, and someone present for every trip on the first night. Reduced mobility also raises the risk discussed in the piece on blood clots after plastic surgery, so walking matters, supervised.

Facility choice. A patient with mild, stable Parkinson's having a short procedure is generally manageable in an accredited outpatient setting. A patient with significant swallowing problems, frequent "off" periods, hallucinations, or a history of falls is better served where there is an anesthesiologist present, overnight observation, and staff who can give medication on a precise schedule. The standards are covered in the piece on outpatient facility accreditation.

Faces, skin, and injectables: masked expression, tremor, drooling, and skin checks

The short answer: Parkinson's can reduce facial expression, cause tremor that complicates procedures under local anesthesia, produce drooling that botulinum toxin can treat, and roughly double melanoma risk according to several large studies, so cosmetic decisions should account for movement, expression, and skin surveillance together.

Reduced facial expression. Hypomimia, often called a "masked face," is a common sign of Parkinson's in which spontaneous facial movement decreases. Patients and families sometimes read it as looking tired, sad, or older, and some seek cosmetic treatment for it. A facelift or eyelid lift can address skin and fat but does not restore movement, and heavy use of neurotoxin can reduce what expression remains. Conservative dosing, or avoiding toxin in areas where movement is already limited, is generally the wiser approach. Eyelid problems also occur: some patients develop reduced blinking, which worsens dry eye, and a few develop blepharospasm or difficulty opening the eyes, which can be mistaken for droopy lids. The distinction between true lid ptosis and other causes is covered in the piece on eyelid ptosis versus blepharoplasty, and the dry-eye risk after surgery is covered in the piece on dry eye after eyelid surgery.

Tremor and dyskinesia during procedures. Resting tremor often lessens with purposeful movement and can be controlled by well-timed medication, while dyskinesias (involuntary writhing movements caused by levodopa at peak effect) can make precise injections or laser work difficult. Scheduling a procedure at the point in the dosing cycle where the patient is "on" but not dyskinetic is a practical solution, and it is a conversation the patient is better placed to lead than anyone else, because they know their own cycle.

Drooling. Excess saliva in the mouth, caused largely by reduced swallowing rather than increased production, is common and socially distressing. The FDA has approved botulinum toxin injections into the salivary glands, incobotulinumtoxinA in 2018 and rimabotulinumtoxinB in 2019, for chronic sialorrhea in adults. This is a medical treatment that cosmetic patients may not know exists, and it is usually delivered by a neurologist or a specialist using ultrasound guidance, not as part of an aesthetic injection visit.

Melanoma and skin surveillance. Large epidemiological studies have consistently found a higher rate of melanoma in people with Parkinson's disease, roughly two times the general population in several analyses, for reasons that are not fully understood. The American Parkinson Disease Association and dermatology guidance support regular skin examinations. Any new or changing spot found during a cosmetic consultation should be examined properly rather than treated cosmetically, as discussed in the piece on cosmetic mole removal, and facial skin cancers needing reconstruction follow the path described in the piece on Mohs reconstruction. Seborrheic dermatitis, a flaky, red rash around the nose, brows, and scalp, is also more common in Parkinson's and should be calm before facial surgery or resurfacing.

Impulse control and repeat procedures. Dopamine agonists such as pramipexole and ropinirole are associated with impulse control disorders, including compulsive shopping and spending, in a meaningful minority of patients. The DOMINION study, a large cross-sectional survey, found impulse control problems in about 14 percent of patients with Parkinson's, with higher rates among those taking dopamine agonists. There is no specific research on cosmetic procedures, but a patient or family member who notices a sudden, uncharacteristic pattern of booking treatment after treatment should raise it with the neurologist, and a thoughtful surgeon will ask the questions described in the piece on body dysmorphic disorder screening.

Finally, keep the records. The anesthesia record, the list of drugs given, and any changes to the Parkinson's regimen should go back to the neurologist, for the reasons explained in the piece on medical records after cosmetic surgery. A worsening of symptoms in the week after surgery is much easier to sort out when the neurologist knows exactly what was given and when.

The honest summary

Parkinson's disease is not a reason to rule out cosmetic surgery. Many patients with stable, well-treated Parkinson's can safely have facial, eyelid, and body procedures, often in accredited outpatient settings. What they need is not a one-line clearance but a plan built around the specific ways Parkinson's interacts with surgery.

That plan starts with time. Levodopa and related medications should be taken at the usual clock times throughout the surgical day, with a sip of water during fasting, the patient booked as the first case, and doses written into the recovery orders. A backup exists before the day for anyone who might not be able to swallow. The drug list matters next: metoclopramide, prochlorperazine, promethazine, droperidol, and haloperidol should be avoided; patients on MAO-B inhibitors should not receive meperidine, tramadol, methadone, or dextromethorphan; and ondansetron should never be paired with apomorphine.

For patients with a deep brain stimulator, the hardware runs through exactly the tissue that facelifts, neck lifts, and chest procedures operate on, so the wire path, the cautery plan, and the device settings must be agreed with the implanting team in advance, and diathermy is contraindicated. Recovery should anticipate swallowing difficulty, low blood pressure on standing, constipation, bladder problems, delirium, and falls. On the aesthetic side, masked expression argues for restraint with neurotoxin, tremor and dyskinesia argue for timing procedures to the dosing cycle, and a higher melanoma rate argues for proper skin checks.

The patient at the top of this piece had the lower facelift and upper eyelid lift as the first case of the morning. They took their 6 a.m. levodopa with a sip of water, brought their own pills, and had each dose written into the recovery orders. The anesthesiologist used dexamethasone and ondansetron for nausea, avoided tramadol because of the rasagiline, and kept the plan opioid-sparing. A partner stayed for the first week with a printed dose chart, a night light, and a shower chair. Recovery was uneventful. The difference was not the surgery. It was that someone finally asked what time they take their pills.